Korea Investment CORP cut its stake in shares of Taro Pharmaceutical Industries Ltd. (NYSE:TARO) by 13.9% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 64,200 shares of the company’s stock after selling 10,400 shares during the period. Korea Investment CORP’s holdings in Taro Pharmaceutical Industries were worth $7,194,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in TARO. Bessemer Group Inc. raised its stake in shares of Taro Pharmaceutical Industries by 138.6% in the second quarter. Bessemer Group Inc. now owns 2,083 shares of the company’s stock valued at $234,000 after buying an additional 1,210 shares in the last quarter. Bank of Montreal Can raised its stake in shares of Taro Pharmaceutical Industries by 7.5% in the second quarter. Bank of Montreal Can now owns 2,128 shares of the company’s stock valued at $238,000 after buying an additional 149 shares in the last quarter. Russell Investments Group Ltd. raised its stake in shares of Taro Pharmaceutical Industries by 7.4% in the second quarter. Russell Investments Group Ltd. now owns 2,257 shares of the company’s stock valued at $253,000 after buying an additional 156 shares in the last quarter. US Bancorp DE raised its stake in shares of Taro Pharmaceutical Industries by 49.4% in the second quarter. US Bancorp DE now owns 2,983 shares of the company’s stock valued at $334,000 after buying an additional 986 shares in the last quarter. Finally, Eagle Global Advisors LLC purchased a new stake in shares of Taro Pharmaceutical Industries during the second quarter valued at $616,000. 16.41% of the stock is owned by hedge funds and other institutional investors.

Shares of Taro Pharmaceutical Industries Ltd. (NYSE:TARO) opened at 101.38 on Thursday. The company has a 50-day moving average price of $114.34 and a 200 day moving average price of $112.91. The company has a market capitalization of $4.11 billion, a price-to-earnings ratio of 9.17 and a beta of 0.64. Taro Pharmaceutical Industries Ltd. has a one year low of $92.28 and a one year high of $137.98.

Taro Pharmaceutical Industries (NYSE:TARO) last released its earnings results on Monday, May 22nd. The company reported $2.05 earnings per share for the quarter. Taro Pharmaceutical Industries had a net margin of 51.90% and a return on equity of 23.08%. The business had revenue of $196.41 million during the quarter. On average, analysts forecast that Taro Pharmaceutical Industries Ltd. will post $9.49 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Taro Pharmaceutical Industries Ltd. (NYSE:TARO) Shares Sold by Korea Investment CORP” was first published by Daily Political and is owned by of Daily Political. If you are reading this report on another website, it was illegally copied and reposted in violation of United States and international trademark & copyright laws. The legal version of this report can be read at https://www.dailypolitical.com/2017/08/10/taro-pharmaceutical-industries-ltd-nysetaro-shares-sold-by-korea-investment-corp.html.

Several brokerages recently weighed in on TARO. BidaskClub lowered Taro Pharmaceutical Industries from a “buy” rating to a “hold” rating in a report on Sunday, July 16th. TheStreet raised Taro Pharmaceutical Industries from a “c” rating to a “b-” rating in a report on Thursday, July 20th. Finally, Credit Suisse Group lowered Taro Pharmaceutical Industries from an “outperform” rating to a “neutral” rating in a report on Tuesday, May 23rd.

Taro Pharmaceutical Industries Company Profile

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc (Taro Canada) and Taro U.SA The Company markets over 200 pharmaceutical products in over 25 countries.

Want to see what other hedge funds are holding TARO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Taro Pharmaceutical Industries Ltd. (NYSE:TARO).

Institutional Ownership by Quarter for Taro Pharmaceutical Industries (NYSE:TARO)

Receive News & Ratings for Taro Pharmaceutical Industries Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Taro Pharmaceutical Industries Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.